United States
Germany
Japan
United Kingdom
China
SIGLEC5 / SIGLEC14 mouse monoclonal antibody, clone 1A5, FITC, Purified
| Applications | FC |
| Reactivities | Chimpanzee, Human |
Antibodies
CD19 mouse monoclonal antibody, clone Bu12, FITC
| Applications | FC |
| Reactivities | Human |
EDG6 (S1PR4) mouse monoclonal antibody, clone 1, FITC
| Applications | FC, WB |
| Reactivities | Human |
alpha 1 Fetoprotein (AFP) rabbit polyclonal antibody, FITC
| Applications | ELISA, IF, IHC |
| Reactivities | Human |
Lactoferrin (LTF) mouse monoclonal antibody, clone NI 25, FITC
| Applications | ELISA, IF, IP, WB |
| Reactivities | Human |
Human IgM mouse monoclonal antibody, clone NI 179, FITC
| Applications | To identify the presence of IgM in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as direct and indirect Immunofluorescence staining of cytoplasmic IgM and cell membrane IgM. General Recommended Dilutions: Histochemical Use: 1/10-1/50 |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9,630.00
5周
Human IgG3 (F(ab)2 specific) mouse monoclonal antibody, clone NI 330 (HP 6050), FITC
| Applications | To identify the presence of IgG3 in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect Immunoperoxidase staining of cytoplasmic IgG3, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50 ELISA: from 1/200 upwards Western blot: from 1/400 upwards |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9,630.00
5周
Human IgG (Isotype Specific) mouse monoclonal antibody, clone NI 335 and NI 343, FITC
| Applications | To identify the presence of IgG in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect immunoperoxidase staining of cytoplasmic IgG, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50 ELISA: from 1/200 upwards Western blot: from 1/400 upwards |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9,630.00
5周
Human IgG4 (pFC specific) mouse monoclonal antibody, clone NI 315 (HP 6206), FITC
| Applications | To identify the presence of IgG4 in Human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect immunoperoxidase staining of cytoplasmic IgG4, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50. ELISA: from 1/200 upwards. Western blot: from 1/400 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9,630.00
5周
Human IgG2 (F(ab)2 specific) mouse monoclonal antibody, clone NI 6014 (HP 6014), FITC
| Applications | To identify the presence of IgG2 in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect immunoperoxidase staining of cytoplasmic IgG2, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50. ELISA: from 1/200 upwards. Western blot: from 1/400 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9,630.00
5周
Human IgG1 (Fc specific) mouse monoclonal antibody, clone NI 132 (HP 6186), FITC
| Applications | To identify the presence of IgG1 in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect immunoperoxidase staining of cytoplasmic IgG1, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50. ELISA: from 1/200 upwards. Western blot: from 1/400 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9,630.00
5周
Human IgG2 (Fc specific) mouse monoclonal antibody, clone NI 25-1 (HP 6207), FITC
| Applications | To identify the presence of IgG2 in Human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as ELISA, indirect immunoperoxidase staining of cytoplasmic IgG2, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/10-1/50. ELISA: from 1/200 upwards. Western blot: from 1/400 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
Human IgD mouse monoclonal antibody, clone NI 158, FITC
| Applications | To identify the presence of IgD in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as direct and indirect immunofluorescence staining of cytoplasmic IgD and cell membrane IgD. General Recommended Dilutions: Histochemical Use: 1/10-1/100. |
| Reactivities | Human |
| Conjugation | FITC |
CNY 9,630.00
5周
Human IgA mouse monoclonal antibody, clone NI 69 (A89-034) and NI 184 (A89-035), FITC
| Applications | To identify the presence of IgA in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as immunofluorescence staining of cytoplasmic IgA, and immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/20-1/100 Western blot: from 1/200 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
Human IgA2 mouse monoclonal antibody, clone NI 512 (A89-038), FITC
| Applications | To identify the presence of IgA2 in human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as Immunofluorescence staining of cytoplasmic IgA2, and Immunoblotting using a peroxidase labelled monoclonal antibody against FITC. General Recommended Dilutions: Histochemical Use: 1/20-1/100. Western blot: from 1/500 upwards. |
| Reactivities | Human |
| Conjugation | FITC |
活动过滤器
优化搜索结果
Target Symbol
- PTPRC (8)
- CD19 (7)
- CD4 (6)
- CD45 (6)
- ITGAM (6)
- CD14 (5)
- CD3E (5)
- CD44 (5)
- CD8A (5)
- FAS (5)
- CD34 (4)
- CD5 (4)
- CD59 (4)
- ENG (4)
- FCGR3A (4)
- KRT18 (4)
- MAP2K2 (4)
- MAPK1 (4)
- MME (4)
- MS4A1 (4)
- TFRC (4)
- CD40 (3)
- CD62E (3)
- CD7 (3)
- CD9 (3)
- CR2 (3)
- EGFR (3)
- GYPA (3)
- HLA-G (3)
- ICAM1 (3)
- IFNG (3)
- ITGAE (3)
- ITGB2 (3)
- PECAM1 (3)
- SELL (3)
- SPN (3)
- TP53 (3)
- ALB (2)
- BCL3 (2)
- C1QA (2)
- CD13 (2)
- CD151 (2)
- CD16 (2)
- CD1A (2)
- CD2 (2)
- CD200 (2)
- CD21 (2)
- CD22 (2)
- CD24 (2)
- CD28 (2)
- CD36 (2)
- CD55 (2)
- CD79A (2)
- CD79B (2)
- CD81 (2)
- CD99 (2)
- CEACAM5 (2)
- CYTOKERATIN 8 (2)
- DCR1 (2)
- EPCAM (2)
- FCGR2A (2)
- GLYCOPHORIN A (2)
- GP9 (2)
- HLA-B (2)
- IL2 (2)
- IL2RA (2)
- INTERFERON GAMMA (2)
- ITGA2B (2)
- ITGB1 (2)
- ITGB3 (2)
- KLRD1 (2)
- LACTOFERRIN (2)
- LAMP1 (2)
- MAP2K1 (2)
- MPO (2)
- NCAM1 (2)
- PDPN (2)
- PRTN3 (2)
- S100A1 (2)
- TEK (2)
- TG (2)
- THY1 (2)
- TLR2 (2)
- TLR4 (2)
- TNFRSF1B (2)
- VASP (2)
- VCAM1 (2)
- VIM (2)
- ADGRE3 (1)
- AFP (1)
- AKT1 (1)
- AKT3 (1)
- ANPEP (1)
- ASGR1 (1)
- B2M (1)
- B7-2 (1)
- BCL2 (1)
- BCL2L1 (1)
- C-MYC (1)
- C3 (1)
Antibody Hosts
Isotypes
Clonalities
Families
- Druggable Genome (95)
- Transmembrane (83)
- ES Cell Differentiation/IPS (42)
- Secreted Protein (26)
- Adult stem cells (12)
- Protease (7)
- Phosphatase (6)
- Cancer stem cells (5)
- Embryonic stem cells (5)
- Transcription Factors (5)
- Induced pluripotent stem cells (3)
- Protein Kinase (2)
- Stem cell - Pluripotency (2)
- Stem cell relevant signaling - DSL/Notch pathway (2)
- Stem cell relevant signaling - JAK/STAT signaling pathway (2)
- GPCR (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- Cell adhesion molecules (CAMs) (39)
- Hematopoietic cell lineage (36)
- T cell receptor signaling pathway (22)
- Primary immunodeficiency (19)
- Cytokine-cytokine receptor interaction (17)
- Natural killer cell mediated cytotoxicity (16)
- Systemic lupus erythematosus (13)
- Allograft rejection (11)
- Complement and coagulation cascades (9)
- Fc gamma R-mediated phagocytosis (9)
- Type I diabetes mellitus (9)
- Autoimmune thyroid disease (8)
- Graft-versus-host disease (8)
- Jak-STAT signaling pathway (8)
- Viral myocarditis (8)
- Antigen processing and presentation (7)
- B cell receptor signaling pathway (7)
- Apoptosis (6)
- Pathways in cancer (6)
- Toll-like receptor signaling pathway (6)
- Focal adhesion (5)
- ECM-receptor interaction (4)
- Leukocyte transendothelial migration (4)
- Regulation of actin cytoskeleton (4)
- Small cell lung cancer (4)
- TGF-beta signaling pathway (4)
- Asthma (3)
- Bladder cancer (3)
- Colorectal cancer (3)
- Endocytosis (3)
- Endometrial cancer (3)
- ErbB signaling pathway (3)
- MAPK signaling pathway (3)
- Prostate cancer (3)
- RIG-I-like receptor signaling pathway (3)
- Adherens junction (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Calcium signaling pathway (2)
- Dilated cardiomyopathy (2)
- Glutathione metabolism (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Metabolic pathways (2)
- Non-small cell lung cancer (2)
- Pancreatic cancer (2)
- Pathogenic Escherichia coli infection (2)
- Prion diseases (2)
- Proteasome (2)
- Regulation of autophagy (2)
- Renin-angiotensin system (2)
- Acute myeloid leukemia (1)
- Adipocytokine signaling pathway (1)
- Alzheimer's disease (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Axon guidance (1)
- Cell cycle (1)
- Chemokine signaling pathway (1)
- Chronic myeloid leukemia (1)
- Cytosolic DNA-sensing pathway (1)
- Dorso-ventral axis formation (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Fc epsilon RI signaling pathway (1)
- Gap junction (1)
- Glioma (1)
- GnRH signaling pathway (1)
- Lysosome (1)
- Melanoma (1)
- NOD-like receptor signaling pathway (1)
- Neuroactive ligand-receptor interaction (1)
- Neurotrophin signaling pathway (1)
- Thyroid cancer (1)
- Type II diabetes mellitus (1)
- Wnt signaling pathway (1)
